Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 1204313-51-8
2. Icotinib (hydrochloride)
3. Icotinib Hcl
4. Bpi-2009h
5. Jtd32i0j83
6. N-(3-ethynylphenyl)-2,5,8,11-tetraoxa-15,17-diazatricyclo[10.8.0.014,19]icosa-1(12),13,15,17,19-pentaen-18-amine;hydrochloride
7. (1,4,7,10)tetraoxacyclododecino(2,3-g)quinazolin-4-amine, N-(3-ethynylphenyl)-7,8,10,11,13,14-hexahydro-, Hydrochloride (1:1)
8. Unii-jtd32i0j83
9. Chembl4297665
10. Dtxsid80152859
11. Hms3750o09
12. Bcp06306
13. Ex-a2070
14. Akos026750418
15. Cs-0918
16. Icotinib Hydrochloride [who-dd]
17. Ac-29741
18. As-78690
19. Da-33566
20. Hy-15164
21. Ft-0701515
22. A13718
23. A925581
24. Q27281690
25. N-(3-ethynylphenyl)-2,5,8,11-tetraoxa-15,17-diazatricyclo[10.8.0.0^{14,19]icosa-1(12),13,15,17,19-pentaen-18-amine;hydrochloride
26. N-(3-ethynylphenyl)-7,8,10,11,13,14-hexahydro-[1,4,7,10]tetraoxacyclododecino[2,3-g]quinazolin-4-amine Hydrochloride
27. N-(3-ethynylphenyl)-7h,8h,10h,11h,13h,14h-1,4,7,10-tetraoxacyclododeca[2,3-g]quinazolin-4-amine Hydrochloride
Molecular Weight | 427.9 g/mol |
---|---|
Molecular Formula | C22H22ClN3O4 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 3 |
Exact Mass | 427.1298839 g/mol |
Monoisotopic Mass | 427.1298839 g/mol |
Topological Polar Surface Area | 74.7 Ų |
Heavy Atom Count | 30 |
Formal Charge | 0 |
Complexity | 553 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
ABOUT THIS PAGE
73
PharmaCompass offers a list of Icotinib Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Icotinib Hydrochloride manufacturer or Icotinib Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Icotinib Hydrochloride manufacturer or Icotinib Hydrochloride supplier.
PharmaCompass also assists you with knowing the Icotinib Hydrochloride API Price utilized in the formulation of products. Icotinib Hydrochloride API Price is not always fixed or binding as the Icotinib Hydrochloride Price is obtained through a variety of data sources. The Icotinib Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Icotinib Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Icotinib Hydrochloride, including repackagers and relabelers. The FDA regulates Icotinib Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Icotinib Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Icotinib Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Icotinib Hydrochloride supplier is an individual or a company that provides Icotinib Hydrochloride active pharmaceutical ingredient (API) or Icotinib Hydrochloride finished formulations upon request. The Icotinib Hydrochloride suppliers may include Icotinib Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Icotinib Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Icotinib Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Icotinib Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Icotinib Hydrochloride GMP manufacturer or Icotinib Hydrochloride GMP API supplier for your needs.
A Icotinib Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Icotinib Hydrochloride's compliance with Icotinib Hydrochloride specifications and serves as a tool for batch-level quality control.
Icotinib Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Icotinib Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Icotinib Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Icotinib Hydrochloride EP), Icotinib Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Icotinib Hydrochloride USP).